Tripartite motif-containing protein 24 (TRIM24) is closely correlated with multiple cancers, and a recent study demonstrated that the bromodomain of TRIM24 is essential for the proliferation of lethal castration-resistant prostate cancer. Here, we identify three new inhibitors of the TRIM24 bromodomain using NMR fragment-based screening. The crystal structures of two new inhibitors in complex with the TRIM24 bromodomain reveal that the water-bridged interaction network is conserved in the same fashion as those for known benzoimidazolone inhibitors. Interestingly, the polar substitution on the warhead of one new inhibitor pulls the whole ligand approximately 2 A into the inner side pocket of the TRIM24 bromodomain, and thus exhibits a binding mode significantly different from other known bromodomain ligands. This mode provides a useful handle for further hit-to-lead evolution toward novel inhibitors of the TRIM24 bromodomain.
Introduction
Selective inhibition of BET (bromo and extraterminal) bromodomains has shown efficacy in treating a variety of disease models, including cancer [1] [2] [3] , inflammation [4] , male contraception [5] , and heart failure [6] . With the recent disclosure of a number of non-BET bromodomain inhibitors, bromodomain family members have become the new frontier of drug discovery [7, 8] . The bromodomain-containing tripartite motif protein 24 (TRIM24, also known as TIF1a) is a member of the TRIM family, and it has an integrated module of a RING finger, B-boxes, and a coiled-coil domain in the N terminus. TRIM24 was first discovered as a transcriptional mediator of multiple nuclear receptors that interact with the LxxLL motif in the middle region of TRIM24 [9, 10] . Later, it was demonstrated that TRIM24 has a close association with multiple cancers, including head and neck squamous cell carcinoma [11] , nonsmall-cell lung cancer [12] , hepatocellular cancer [13, 14] , glioblastoma [15] , and gastric cancer [16] . The knockdown of TRIM24 suppresses cell growth and induces apoptosis in colon cancer cells [17] . The overexpression of TRIM24 correlates with poor overall survival of breast cancer patients [18] [19] [20] . The C-terminal tandem plant homeodomain (PHD) of TRIM24 recognizes unmodified histone H3K4, while the bromodomain binds to acetylated histone H3 at Abbreviations BET, bromo and extraterminal; FP, fluorescence polarization; H4K16ac, acetylated histone H4 at K16; HSQC, heteronuclear single-quantum coherence; ITC, isothermal titration calorimetry; NMR, nuclear magnetic resonance; PHD, plant homeodomain; TRIM24, tripartite motifcontaining protein 24. K23, acetylated histone H4 at K16 (H4K16ac) [20] , and to acetylated p53 [21] . TRIM24 is up-regulated in castration-resistant prostate cancer, and this is caused by mutations in speckle-type POZ protein, an E3 ubiquitin ligase substrate-binding protein [22, 23] . Despite the close association of TRIM24 with these disease models, the multidomain architecture of TRIM24 makes it difficult to attribute observed phenotypes to a designated domain. A recent study disclosed that the bromodomain mutants of TRIM24 are incapable of rescuing proliferation in TRIM24-depleted prostate cancer cells, thus nominating the TRIM24 bromodomain as a new anticancer therapeutic target [23] .
The benzoimidazolone scaffold was originally identified from NMR fragment-based screening against the N-terminal bromodomain of BRD4 [24] . Further optimization of this fragment-screening hit generated two highly similar BRPF-TRIM24 bromodomain inhibitors [25, 26] . The complex structures of the TRIM24 bromodomain with its inhibitors show that the benzoimidazolone warhead mimics the natural substrate acetylated lysine, while the water-bridged interaction network is conserved in the free and bound form of the TRIM24 bromodomain. Such a water-bridged interaction network is disturbed by butyryl-lysine, crotonyl-lysine [27] or a nonpolar substitution over the head groups of the bromodomain inhibitors [28] . Undesirably, the nonpolar substitution replaces water molecules in the binding pocket, thus breaking the water-bridged hydrogen bond interactions and leading to a binding energy penalty. Weaker binding and lower ligand efficiency are generally observed for such a nonpolar substitution [28] . It remains unknown whether the polar substitution of TRIM24 bromodomain inhibitors can penetrate the water-bridged network with an enhanced affinity, which would uncover a novel binding mode between bromodomains and inhibitors.
Here, we identified five hits for the TRIM24 bromodomain using NMR fragment-based screening. The protein-ligand binding was further validated using fluorescence polarization (FP) and isothermal titration calorimetry (ITC). Three identified inhibitors are remarkably different from benzoimidazolone. Structures for two of these inhibitors in complex with the TRIM24 bromodomain diffracted at the resolutions of 1.95 and 1.90
A. The complex structures reveal that both inhibitors form hydrogen bonds with residue N980 and a water molecule, and the water-bridged interaction network was well conserved. Thus, we designed a polar substituent for one inhibitor with an enhanced affinity for the TRIM24 bromodomain. The new ligand penetrates 2 A deeper into the acetyl-lysine recognition pocket of the TRIM24 bromodomain, squeezing one water molecule out of the pocket and remarkably rearranging the water-bridged interaction network. Such an interaction mode reveals a way to create novel TRIM24 bromodomain inhibitors that may directly interact with binding-site residues to gain higher potency and specificity.
Results
Using our automated NMR fragment-based screening [29, 30] , we identified 22 hits in the first round of screening against small-molecule cocktails and validated 14 hits in the second round of screening against each individual hit (Fig. 1A,B) . The titration of these hits with the 15 N-labeled TRIM24 tandem PHD-bromodomain (Fig. 1C,D) confirmed five hits that bind to the acetyl-lysine recognition pocket of TRIM24 bromodomain ( Fig. 2A,B) . The dose-dependent chemical shift changes also allowed the determination of the binding affinities of these five hits (Table 1) . We further evaluated the small-molecule inhibition effect of the TRIM24 bromdomain binding to the natural substrate H4K16ac. The TRIM24 PHD-bromodomain binds to H4K16ac (residue [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] with an affinity of 39 lM in our FP assay (Fig. 2C ), which agrees with the previously reported value of 20 lM using ITC [20] . The competitive FP experiment further demonstrates that hit 2 displaces fluorescent H4K16ac from the TRIM24 bromodomain in a dose-dependent manner (Fig. 2D ). Among these hits, hits 4 and 5 shared a similar benzoimidazolone scaffold with known TRIM24 bromodomain inhibitors, while hits 1-3 were remarkably different from benzoimidazolone (Table 2) , indicating the feasibility of uncovering new interaction modes with the TRIM24 bromodomain.
We then soaked the identified fragment-screening hits 1-3 with the TRIM24 bromodomain, and the crystal structures of hits 1 and 2 were solved (Fig. 3A , B and Table 3 ). TRIM24 bromodomain adopts a conserved left-handed four-helix bundle. The rms deviations of the C a atoms of the TRIM24 bromodomain in these two complex structures with respect to the free form are 0.15 and 0. 21 A, respectively. Thus, the binding of compounds 1 and 2 induced little structural change in the TRIM24 bromodomain. The complex structure reveals that hit 1 forms a hydrogen bond with the side chain of residue N980, a conserved residue for hydrogen-bonding interaction with acetyllysines (Fig. 3C) . Water molecule 1, as numbered by Flynn [27] and Hewings et al. [31] , bridges the polar interaction between the phenol group of residue Y935 and the carbonyl group of hit 1. The tetrahydroquinoline group of hit 1 lies in the hydrophobic cave formed by residues V928, P929, V932, and F979, while the methyl ester group of hit 1 probes deeper into the pocket surrounded by the hydrophobic residues A923, F924, and V986. Compound 2 interacts with the TRIM24 bromodomain using a similar pattern with respect to 1, with the addition of the amide group of 2 forming an extra hydrogen bond with the backbone carbonyl of A923 (Fig. 3D) .
The crystal structures of the TRIM24 PHD-bromodomain in complex with hit 1 or 2 reveal five water molecules in the acetyl-lysine binding pocket (Fig. 4A,  B) . These water molecules arrange in an almost identical pattern with those in the crystal structures of the TRIM24 PHD-bromodomain in complex with either the typical benzoimidazolone inhibitor 8i [26] or H4K16ac [20] (Fig. 4C,D) . The oxygen atoms of hit 1 or 8i act as a warhead to mimic the interaction between the acetylated lysines and the TRIM24 bromodomain (Fig. 4C) . A similar pattern was observed upon the superimposition of hit 2 on 8i and H4K16ac (Fig. 4D) . Interestingly, the shortest distance between the conserved water molecules and the warhead of 2 is A, indicating the feasibility of rearranging the water-bridged interaction network using a polar substituent of 2.
Thus, we introduced an amine group in the acetylamide warhead of hit 2. Compound 6, the polar substituent of hit 2, bound to the TRIM24 bromodomain with a higher affinity of 100 lM ( Fig. 5 and Table 1 ). To elucidate the interaction mode, we solved the crystal structure of inhibitor 6 in complex with the TRIM24 PHD-bromodomain (Fig. 6A) . Superimposition of compound 6 onto 2 reveals that 6 penetrates approximately 2
A deeper into the pocket of the TRIM24 bromodomain. Thus, compound 6 squeezes out water molecule 1 and repositions the remaining four water molecules that are 0.9-3.0 A away (Fig. 6B ). The carbonyl of compound 6 displaces water molecule 1 and forms a direct hydrogen bond with the side chain of N980. The NH of compound 6 protrudes 2. 3 A inside and thus forms a hydrogen bond with water molecule 3 0 instead of A923 (Fig. 6C,D) . Meanwhile, the NH 2 group of compound 6 protrudes into the water-bridged interaction network to form a direct hydrogen bond with the carbonyl group of I972 and a new waterbridged interaction with water molecule 0 0 . The repositioning of water molecule 0 also shifts its interaction to N975 instead of M943. Water molecule 2 is now pushed into the inner cave and forms completely new interactions with residues M943, Y935, and I972, and 6 interacts with A923, F924, V928, V932, and C976 through hydrophobic interactions. (Fig. 6E) . The conserved water-bridged interaction network for compound 2 ( Fig. 6C ) is consequently largely rearranged in the complex structure of compound 6 (Fig. 6D) . The crystal structures of the TRIM24 PHD-bromodomain in complex with 2 and 6 were obtained using soaking and cocrystallization, respectively, it then brings out a question of whether this 2-A movement and the water rearrangement are due to the difference in the crystallization methods. This is, however, less likely since the water-mediated interaction networks are conserved in the crystal structures of the TRIM24 PHD-bromodomain in complex with acetylated histones or inhibitor 8i and its analogs [25, 26] , which were almost exclusively obtained using cocrystallization except one inhibitor using soaking (PDB code: 4YAD). Since the binding modes and water-bridged interaction network are strikingly different for compound 2 and 6, the chemical shift perturbations of residues proximal to these water molecules were expected to be different upon the titration of 2 and 6. The largest chemical shift perturbation relative to the free form protein upon the titration of 6 was observed for residue F924 (Fig. 7A) , which is possibly due to the relative large chemical environment changes by the reposition of water molecule 2, as well as the protruding of compound 6 relative to 2 (Fig. 7B) . Table 1 . Affinity and ligand efficiency for fragment-based screening hits or the analog targeting the TRIM24 bromodomain. To further address the enthalpy and entropy contributions from the release of the structured water in the acetyl-lysine binding pocket of the protein and the desolvation of the polar group of compound 6, we performed the ITC experiments for the binding of the TRIM24 PHD-bromodomain to compounds 2 and 6. The affinities were determined using ITC as 63 and 34 lM for 2 and 6 ( Fig. 8) , respectively, which agrees with those measured by NMR chemical shift perturbations (Table 1 ). The ITC accuracy is somehow limited by the aqueous solubility of the TRIM24 PHD-bromodomain and compound 6. Nevertheless, more entropy but not enthalpy contributions to the binding free energy were observed for 6 relative to 2.
In general, the protruding of the polar head group of 6 toward the acetyl-lysine recognition pocket of the TRIM24 bromodomain suggests a novel binding mode, which will accelerate the structure-guided discovery of the TRIM24 bromodomain inhibitors of new chemotypes. The binding mode of compound 6 is in general quite different from those observed for the crotonyl-lysine, butyryl-lysine [27] , and the TAF1 second bromodomain inhibitors with nonpolar substitutions [28] . The butyryl, butenyl, or crot substitution did not reposition the pharmacophore of the ligand into the inside of the pocket. Instead, these nonpolar substituents displaced water molecule 4 and rearranged the water-bridged network.
Discussion
The TRIM24 bromodomain has been nominated as a new anticancer therapeutic target since the proliferation of castration-resistance prostate cancer cells is suppressed by the deletion of this domain [23] . Two benzoimidazolone inhibitors with a high affinity for the bromodomains of TRIM24 and BRPF1 have been discovered, but proof-of-concept at the cellular level has not yet been disclosed [25, 26] . Due to the potential off-target effects of small-molecule inhibitors within the complicated cellular environment, it poses a grand challenge to ascribe a phenotype to the inhibition of a specific protein domain. Therefore, it is highly desirable to discover more TRIM24 bromodomain inhibitors with a new pharmacophore. Three of our identified NMR fragment-based screening hits are structurally different from the known benzoimidazolone inhibitors. The structure of the TRIM24 bromodomain in complex with hit 2 reveals an additional hydrogen bond between the compound and the backbone of A923. This new binding mode reveals a way to optimize the warhead of TRIM24 bromodomain inhibitors. Although much effort has been put into the optimization of the interactions between small-molecule inhibitors and the ZA channel of bromodomains for proteins, including TRIM24 [25, 26] , BRD4 [32] , and BRD9 [33] , the smallmolecule warhead protruding into the hydrophobic acetyl-lysine binding pocket has not yet been exploited. These warheads can indeed dive into the water-bridged interaction network, as is the case for the nonpolar substituents of bromodomain inhibitors for BRD4 and TAF1 [28] , but with an undesirable energy penalty. The polar substituent of the fragment-based screening hit enhances its affinity to TRIM24 bromodomain, and the hit exhibits a remarkably distinguished binding mode. This substituent drags the whole compound approximately 2
A deeper into the acetyl-lysine recognition pocket. This movement repels one conserved water molecule out of the pocket and rearranges all the watermediated interactions. Our work enables the discovery of new inhibitors by optimizing the interaction inside of the hydrophobic pocket, which may initiate a review of the current bromodomain inhibitors.
Experimental procedures

Protein expression and purification
The TRIM24 PHD-bromodomain (residue 824-1006) gene was amplified from human brain and bone marrow cDNA libraries (Clontech, Beijing, China) and cloned into the pETsumo vector (GE Healthcare, Shanghai, China) with a His 6 tag. The construct was then transformed into Escherichia coli BL21. Cells were cultivated in 1 L of LB media containing 0.2 mM ZnSO 4 . After the A 600 nm reached 1.0, IPTG (0.2 mM) was added to the media to induce the expression of the TRIM24 PHD-bromodomain at 16°C. After 20 h, the E. coli cells were harvested by centrifugation and suspended in binding buffer (20 mM Tris and 1 M NaCl, pH 8.0). The cells were then crushed by a high-pressure cell cracker, and the lysate was centrifuged. The supernatant was loaded onto a nickel column (QIAGEN, GE Healthcare, Shanghai, China) and eluted using a linear imidazole gradient. The eluted protein was dialyzed into digestion buffer (20 mM Tris and 200 mM NaCl, pH 8.0) and treated with the enzyme Ulp1 overnight. The digested protein was then loaded onto a nickel column to remove the cleaved His-sumo tag and His-tagged Ulp1 enzyme. The collected TRIM24 protein was further purified with a HiLoad16/ 600 Superdex 75 column (GE Healthcare) in a buffer containing 20 mM Tris, 500 mM NaCl and 5 mM DTT at pH 8.0. Finally, the protein was dialyzed into a low-salt concentration buffer (20 mM Tris and 50 mM NaCl, pH 8.0) and purified using a Mono Q column (GE Healthcare). Crystallization, data collection, and structure determination
Protein samples were concentrated to 20 mgÁmL À1 in a buffer containing 20 mM Tris, 100 mM NaCl, and 5 mM DTT at pH 8.0. The unbound TRIM24 PHD-bromodomain crystals were generated by mixing 1 lL protein and 1 lL reservoir solution containing 2.0 M ammonium sulfate, 0.1 M HEPES buffer (pH 7.5) and 2% PEG400. Crystallization trials were carried out using the sitting drop vapor diffusion method at 20°C. The complex structures were obtained by either cocrystallization or soaking crystals with small molecules. Compounds 1 and 2 at 8 mM in 2 lL of reservoir solution were soaked with the crystals for 48 h. The cocrystallized structure of compound 6 in complex with the TRIM24 PHD-bromodomain was obtained by first incubating 1 mM of compound 6 with the protein at room temperature for 1 h and then mixing 1 lL of the protein-ligand complex with 1 lL of the reservoir solution.
All crystallographic data were collected at beamline BL19U at the Shanghai Synchrotron Radiation Facility (SSRF). Integration and scaling were completed with the program HKL2000 [34] . The structure was determined using the Molrep [35] program of ccp4 [36] with TRIM24 PHDBromo (PDB code: 3O33) [20] as the search model using the molecular replacement method. The initial model was built with COOT [37] and further refined using REFMAC5 [38] and PHENIX [39] . Ligands were first processed by PHENIX and then built into the 2Fo-Fc and Fo-Fc maps at the final stage of the refinement. All the figures were prepared using PyMOL. The crystallographic data and refinement statistics of the individual structures are summarized in Table 3 .
NMR fragment-based screening
All fragment-screening experiments were carried out using an Agilent 700 MHz spectrometer equipped with a 96-well autosampler and cryoprobe. The ligand-based NMR spectra, including the saturation transfer difference (STD) [40] , WaterLOGSY [41] , and CPMG [42] , were acquired during primary screening against 89 fragment cocktails. Each cocktail contained 10 compounds at 0.4 mM and 10 lM of TRIM24 PHD-bromodomain in PBS buffer containing 50% D 2 O. The experimental setting of the NMR 1D proton, STD, and WaterLOGSY was the same as previously described [29] . In general, the 1D proton spectra were acquired using the WATERGATE (w5) pulse for water suppression [43] . The STD experiments used a 2-s Gauss pulse train with the irradiation frequency at À0.7 ppm or À50 ppm alternatively. The WaterLOGSY spectra were acquired using a 1.3-s NOE mixing time for a total acquisition time of 15.1 min. The CPMG pulse scheme was applied for a T 2 relaxation delay of 1 s using a train of 180°squared pulses with 1 ms interpulse delay. The chemical shifts and peak multiplicities retrieved from STD, WaterLOGSY, and CPMG spectra were compared with the reference 1 H spectra for each individual compound in 50% D 2 O. The identified primary hits were further confirmed in a secondary screening for singletons. The NMR spectra of the primary and second screenings were automatically processed and visualized using custom-designed ACD/Labs scripts.
NMR chemical shift perturbation
The 15 N-labeled protein was concentrated to 0.05 or 0.1 mM in PBS buffer (20 mM PBS and 100 mM NaCl at pH 8.0). The compounds were stocked in methanol at a concentration of 25 mM. The aqueous solubility of the compounds was determined using quantitative NMR [29] .The chemical shift assignment was retrieved from the literature [44] . The heteronuclear single-quantum coherence (HSQC) spectra were acquired using a series of ligand vs. protein molar ratios of 0.0, 0.5, 1.0, 2.0, 4.0, and 8.0 on either an Agilent 500 MHz spectrometer equipped with a room temperature probe or an Agilent 700 MHz spectrometer. The binding affinity constant was best-fitted using the following equation assuming a 1 : 1 binding mode [45] , 
Fluorescence polarization
The H4(1-20)K16ac peptide labeled with FITC was purchased from GL Biochem Ltd (Shanghai, China). The peptide stock solution of 10 lM was prepared in the 20 mM Tris buffer (50 mM NaCl at pH 8.0), and the TRIM24 PHD-bromodomain was dialyzed to the same buffer. The aliquots of 200 lL each contained 100 nM peptide and the TRIM24 PHD-bromodomain, whose concentrations varied from 200 lM to 0.78 lM. These samples were added to a 96-well Greiner blk/ clrbtm plate. The fluorescence polarization values were read at 525 nM with an excitation at 485 nM using SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA) at 295 K. Three biological duplicates were carried out for error estimation. The binding affinity was best-fitted using a similar equation to NMR chemical shift perturbations according to the technical resource guide of fluorescence polarization (fourth edition, Invitrogen, Madison, WI, USA, 2006). For competitive FP assays, similar procedures were followed except that each aliquot of 200 lL contained 100 nM peptide, 100 lM TRIM24 PHD-bromodomain, and compound 2 with a varied concentration from 75 lM to 1200 lM.
Isothermal titration calorimetry
Isothermal titration calorimetry experiments were performed on a MicroCal ITC200 calorimeter (Malvern Instruments Ltd, Malvern, UK) at 298 K. The TRIM24 PHD-bromodomain was dialyzed into a 20 mM Tris buffer (200 mM NaCl at pH 8.0), which was also used to dissolve the small molecules. The microcell was filled by 200 lL of compound solution at 150 lM, while the microsyringe was loaded with the protein solution at 1.5 mM. Twenty injections were carried out with the first injection of 1 lL followed by 19 identical injections of 2 lL each, with a stirring rate of 1000 rpm, a 150-s delay between injections and a reference power of 5 lcalÁs À1 . The first two injections were discarded for data analysis. The ITC data were analyzed using the Origin 7.5 and best-fitted to the one-site binding model to determine the binding enthalpies and affinity constants. The binding entropies were calculated using the Gibbs free energy equation.
